Alyeska Investment Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-52,500
Closed -$6.23M 700
2022
Q1
$6.23M Buy
+52,500
New +$6.23M 0.07% 263
2021
Q4
Sell
-60,954
Closed -$8.47M 822
2021
Q3
$8.47M Buy
+60,954
New +$8.47M 0.1% 225
2020
Q1
Sell
-60,934
Closed -$3.32M 525
2019
Q4
$3.32M Buy
60,934
+10,233
+20% +$557K 0.04% 243
2019
Q3
$2.12M Sell
50,701
-144,545
-74% -$6.03M 0.03% 266
2019
Q2
$8.55M Buy
+195,246
New +$8.55M 0.11% 178
2017
Q3
Sell
-149,651
Closed -$3.74M 579
2017
Q2
$3.74M Buy
+149,651
New +$3.74M 0.03% 288